Cellosaurus logo
expasy logo

Cellosaurus ZJU-1125 (CVCL_XE05)

[Text version]
Cell line name ZJU-1125
Accession CVCL_XE05
Resource Identification Initiative To cite this cell line use: ZJU-1125 (RRID:CVCL_XE05)
Comments Group: Patented cell line.
Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017176.
Population: Chinese.
Doubling time: 44.73 hours (PubMed=31359275).
Karyotypic information: Near triploid karyotype (PubMed=31359275).
Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
Sequence variations
Disease Intrahepatic cholangiocarcinoma (NCIt: C35417)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 57Y
Category Cancer cell line
STR profile Source(s): PubMed=31359275

Markers:
AmelogeninX
CSF1PO12,13
D5S81811,12
D7S82011
D13S3178
D16S53912,13
TH019
TPOX8,11
vWA16

Run an STR similarity search on this cell line
Publications

Patent=CN108048401A
Sun J.-H., Yang X.-M., Zhou F., Zhang Y.-H.
Human biliary tract cancer cell lines and application.
Patent number CN108048401A, 18-May-2018

PubMed=31359275; DOI=10.1245/s10434-019-07649-5
Zhang Y.-H., Luo J.-F., Dong X., Yang F., Zhang M.-F., Zhao J.-J., Wang Q.-F., Zhou F., Sun J.-H., Yang X.-M.
Establishment and characterization of two novel cholangiocarcinoma cell lines.
Ann. Surg. Oncol. 26:4134-4147(2019)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

Cross-references
Cell line databases/resources cancercelllines; CVCL_XE05
CCRID; 4201PAT-CCTCC01129
Encyclopedic resources Wikidata; Q98136534
Entry history
Entry creation06-Sep-2019
Last entry update05-Oct-2023
Version number10